[Effect of dysproteinemic serums on the resistence of normal erythrocytes].
D000208:Acute Disease / Q000097:blood; D000510:Alpha-Globulins; D001796:Blood Protein Disorders / Q000503:physiopathology*; D002462:Cell Membrane; D004912:Erythrocytes / Q000502:physiology*; D006461:Hemolysis; D006505:Hepatitis / Q000097:blood; D006689:Hodgkin Disease / Q000097:blood; D006801:Humans; D007239:Infections / Q000097:blood; D007674:Kidney Diseases / Q000097:blood; D007938:Leukemia / Q000097:blood; D008103:Liver Cirrhosis / Q000097:blood; D008206:Lymphatic Diseases / Q000097:blood; D009101:Multiple Myeloma / Q000097:blood; D009362:Neoplasm Metastasis / Q000097:blood; D009996:Osmotic Fragility; D010488:Polyarteritis Nodosa / Q000097:blood; D005719:gamma-Globulins
D000510:Alpha-Globulins; D005719:gamma-Globulins
Der Einfluss dysproteinämischer Seren auf die Resistenz normaler Erythrozyten.